Jacksonville, NC5 Active Studies

Multiple Sclerosis Clinical Trials in Jacksonville, NC

Find 5 actively recruiting multiple sclerosis clinical trials in Jacksonville, NC. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
51,144
Enrolling

Recruiting Multiple Sclerosis Studies in Jacksonville

About Multiple Sclerosis Clinical Trials in Jacksonville

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 5 multiple sclerosis clinical trials recruiting participants in Jacksonville, NC. These studies are seeking a combined 51,144 participants. Research is being sponsored by Proton Collaborative Group, Axsome Therapeutics, Inc., GlaxoSmithKline and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Jacksonville — FAQ

Are there multiple sclerosis clinical trials in Jacksonville?

Yes, there are 5 multiple sclerosis clinical trials currently recruiting in Jacksonville, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Jacksonville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Jacksonville research site will contact you about next steps.

Are clinical trials in Jacksonville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Jacksonville studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 5 active trials in Jacksonville are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated July 13, 2026 from ClinicalTrials.gov